首页> 美国卫生研究院文献>Clinical Cosmetic and Investigational Dentistry >Should Quality of Glycemic Control Guide Dental Implant Therapy in Patients with Diabetes? Focus on: Peri-Implant Diseases
【2h】

Should Quality of Glycemic Control Guide Dental Implant Therapy in Patients with Diabetes? Focus on: Peri-Implant Diseases

机译:糖尿病患者是否应质量血糖控制指南牙科植入治疗?专注于:Peri-植入疾病

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Traditionally patients with metabolic conditions such as diabetes mellitus are considered not suitable candidates for dental implant therapy due to increased risk of infection, impaired bone healing or the potential for vascular complications. Peri-implantitis as the more progressive form of peri-implant disease involves bone loss and estimated to occur in nearly half of all implant cases long-term. Despite extensive research on association of hyperglycemia with dental implants in preclinical and animal models, translational effort to clinical practice is hampered by discrepancies in reported outcome indicators for peri-implantitis in patients with a spectrum of glycemic profiles. This review aims to evaluate clinical evidence for peri-implant disease in metabolically compromised patients and in particular in patients with poorly-controlled diabetes in order to inform clinical management of peri-implant disease.
机译:传统上,由于感染的风险增加,骨愈合受损或血管并发症的可能性,传统上,患有糖尿病的代谢病症(如糖尿病)的患者被认为是牙科植入治疗的候选者。 Peri-植入炎作为围植入病的较前植入形式涉及骨质损失,估计在近一半的植入病例中长期发生。尽管对临床前和动物模型的牙科植入物与牙科植入物的关联进行了广泛的研究,但临床实践的翻译努力是通过报告的血糖型患者患者患者的报告结果指标的差异而受到阻碍。本综述旨在评估代谢损害患者患者患者的临床证据,特别是对糖尿病患者的患者,以便为脑植入疾病提供临床管理。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号